Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Ellemunter

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Pediatric Transplantation|September 24, 2005
Long-term glomerular filtration rate following pediatric liver transplantationSilke Wiesmayr, Therese C Jungraithmayr, Helmut Ellemunter, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, et al.
Respiratory Medicine|July 20, 2010
Sensitivity of Lung Clearance Index and chest computed tomography in early CF lung diseaseHelmut Ellemunter, Susanne I Fuchs, Karin M Unsinn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2020
Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutationsAnne Munck, Eitan Kerem, Helmut Ellemunter, et al.
Nanomedicine (London, England)|March 1, 2018
Amikacin-containing self-emulsifying delivery systems via pulmonary administration for treatment of bacterial infections of cystic fibrosis patientsGergely Hetényi, Janine Griesser, Simon Fontana, et al.
Respiratory Medicine|December 18, 2014
Cystic fibrosis (CF) care through the patients' eyes - a nationwide survey on experience and satisfaction with services using a disease-specific questionnaireGratiana Steinkamp, Katja Stahl, Helmut Ellemunter, et al.
International Journal of Molecular Sciences|October 26, 2024
Cytokines Measured in Nasal Lavage Compared to Induced Sputum in Patients with Mild Cystic FibrosisTeresa Fuchs, Artemis Vasiliadis, Manuela Zlamy, et al.
ERJ Open Research|March 18, 2026
Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis RegistryStefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, et al.
International Journal of Pharmaceutics|June 9, 2018
Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin with improved mucus permeating propertiesSergey Zaichik, Christian Steinbring, Claudia Menzel, et al.
BMC Pulmonary Medicine|June 18, 2024
Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assaysTeresa Fuchs, Manuela Zlamy, Thomas Zöggeler, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Pediatric Transplantation|September 24, 2005
Long-term glomerular filtration rate following pediatric liver transplantationSilke Wiesmayr, Therese C Jungraithmayr, Helmut Ellemunter, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, et al.
Respiratory Medicine|July 20, 2010
Sensitivity of Lung Clearance Index and chest computed tomography in early CF lung diseaseHelmut Ellemunter, Susanne I Fuchs, Karin M Unsinn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2020
Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutationsAnne Munck, Eitan Kerem, Helmut Ellemunter, et al.
Nanomedicine (London, England)|March 1, 2018
Amikacin-containing self-emulsifying delivery systems via pulmonary administration for treatment of bacterial infections of cystic fibrosis patientsGergely Hetényi, Janine Griesser, Simon Fontana, et al.
Respiratory Medicine|December 18, 2014
Cystic fibrosis (CF) care through the patients' eyes - a nationwide survey on experience and satisfaction with services using a disease-specific questionnaireGratiana Steinkamp, Katja Stahl, Helmut Ellemunter, et al.
International Journal of Molecular Sciences|October 26, 2024
Cytokines Measured in Nasal Lavage Compared to Induced Sputum in Patients with Mild Cystic FibrosisTeresa Fuchs, Artemis Vasiliadis, Manuela Zlamy, et al.
ERJ Open Research|March 18, 2026
Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis RegistryStefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, et al.
International Journal of Pharmaceutics|June 9, 2018
Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin with improved mucus permeating propertiesSergey Zaichik, Christian Steinbring, Claudia Menzel, et al.
BMC Pulmonary Medicine|June 18, 2024
Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assaysTeresa Fuchs, Manuela Zlamy, Thomas Zöggeler, et al.
Pageof 5